×

Equipment and Services Health Care Equipment and Supplies

  • The TAVR market in which Edwards Lifesciences Corp is considered the leader could potentially exceed $5 billion by 2021, and grow 10 percent to 15 percent for the foreseeable future, Leerink analysts said in a note. The Marlborough, Massachusetts- based company had suspended implants of its next-generation Lotus Edge device in Europe last October over...

  • Boston Scientific had suspended implants of its next-generation Lotus Edge device in Europe last October over similar concerns, but last month said it had found a fix for the issue. The company has pushed the submission of its marketing application for the device in the United States to the fourth quarter, and expects to launch it in mid-2018.

  • Feb 23- Boston Scientific Corp said on Thursday it was recalling its Lotus Valve heart devices, citing reports of problems with the locking mechanism, sending its shares down 8 percent in premarket trading. Boston Scientific had suspended implants of another valve system, Lotus Edge, in Europe last October over similar concerns. The company said it continues to...

  • Feb 23- Boston Scientific Corp said on Thursday it was recalling its range of Lotus Valve heart devices, citing reports of problems with the locking mechanism. The products are expected to return to the European market and in other regions in the fourth quarter, the company added. The company's stock was down 9.4 percent at $22.79 in premarket trading.

  • Feb 21- The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices. Boston Scientific had asked the justices to hear its appeal in the dispute over its licenses...

  • Feb 21- The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

  • TEL AVIV, Feb 21- Israel's BrainStorm Cell Therapeutics is seeking early approval in Canada for its adult stem cell treatment for patients with amyotrophic lateral sclerosis, a neuro-degenerative disease, even before it completes late-stage clinical trials. At the same time, BrainStorm will conduct a Phase 3 clinical trial for NurOwn at multiple sites in the...

  • A man walks out of the Univista Insurance company office after shopping for a health plan under the Affordable Care Act, on December 15, 2015, in Miami.

    Former Aetna CEO Ron Williams weighs in on what changes could be ahead for the Affordable Care Act and consumers.

  • Athletes are going beyond wearable fitness trackers

    "Blueprint for Athletes" is a service by Quest Diagnostics that provides diagnostic insights to help committed athletes improve their performance.

  • What happens during atrial fibrillation

    As many as 6 million Americans have atrial fibrillation, the most common form of cardiac arrhythmia. It’s caused when the electrical signaling that keeps our hearts beating becomes erratic, and, in its most serious forms, can lead to stroke or heart failure.

  • AMSTERDAM, Jan 24- Medical equipment maker Philips missed forecasts for fourth-quarter earnings on Tuesday and disclosed a dispute with the U.S. Justice Department over heart defibrillators it had sold until 2016, but said the matter would not alter its medium term outlook. Van Houten said Philips' defibrillator business would be "impacted" but the scope was...

  • WASHINGTON, Jan 18- Texas- based medical device company Orthofix International NV has admitted wrongdoing and agreed to pay more than $14 million to settle charges that it improperly booked revenue and paid off doctors in Brazil to boost sales, U.S. regulators said on Wednesday. The Securities and Exchange Commission said in a statement that Orthofix...

  • Jan 9- Abbott Laboratories moved to protect patients with its St. Jude heart implants against possible cyber attacks, releasing a software patch on Monday that the firm said will reduce the "extremely low" chance of them being hacked. The patch that Abbott began pushing out to patients on Monday addresses vulnerabilities that present the greatest risk to...

  • The FDA confirmed claims that cyber "vulnerabilities" could allow a hacker to remotely access St. Doctors and patients have been waiting for action from the FDA and St. Jude since August when short-selling firm Muddy Waters and cyber security firm MedSec Holdings claimed the implanted heart devices were riddled with potentially lethal security bugs.

  • Jan 9- Abbott Laboratories said on Monday it has begun releasing cyber security updates for its St. Abbott announced the updates as the U.S. Food and Drug Administration issued a Safety Communication advising patients and physicians to keep using the company's implanted cardiac devices following the updates. "The FDA conducted an assessment of the benefits...

  • FDA SAYS THERE HAVE BEEN NO REPORTS OF PATIENT HARM RELATED TO CYBER VULNERABILITIES IN ST JUDE HEART DEVICES.

  • FOOD AND DRUG ADMINISTRATION RELEASES SAFETY COMMUNICATION ON ABBOTT'S ST JUDE MEDICAL DEVICES.

  • ABBOTT LABORATORIES SAYS RELEASES CYBER SECURITY UPDATES FOR ST JUDE HEART DEVICES AFTER FDA SAFETY PROBE.

  • Theranos laying off another 155 employees

    The company says it will part ways with 155 employees, leaving a core team of only 220 workers.

  • WASHINGTON, Dec 27- Healthcare company Abbott Laboratories has won U.S. antitrust approval for its proposed $25 billion acquisition of medical device maker St. Jude Medical Inc, the U.S. Federal Trade Commission said on Tuesday. Jude's vascular closure device and Abbott's steerable sheath to Japan- based Terumo Corp. In October, Abbott said the companies would...